Products


We make a wide range of prescription medicines, vaccines and consumer healthcare products.

In March 2015 we completed a 3-part transaction with Novartis which reshapes our business. We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. In addition, Novartis acquired our marketed Oncology portfolio and the R&D activities related to it.

As the integration of this business units progresses, this website will be updated to reflect the expanded portfolio of vaccines and consumer healthcare products.